Clinical Trial

A Study on the Safety and Effectiveness of the Mantra™ Surgical Robotic System for Soft Tissue Surgeries

Study acronym: MARS
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 16, 2025 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
A Real-World, multicentre retrospective study to evaluate the clinical performance and safety of MantraTM Surgical Robotic System for soft tissue surgeries. The purpose of this retrospective study is to evaluate the clinical performance and safety of the Mantra™ Surgical Robotic System, Model 3.0, for soft tissue surgeries. It aims to provide real-world evidence on the system's reliability, safety, and effectiveness in the real world population. The SSI Mantra 3.0 Surgical Robotic System is an advanced, modular, and cost-effective robotic-assisted surgical platform designed to enhance precision, flexibility, and control in minimally invasive surgeries (MIS). The objective of this retrospective study is to assess the clinical performance and safety of the Mantra™ Surgical Robotic System in performing various soft tissue surgeries based on retrospective data analysis.
Trial Details
NCT Number NCT06974955
Lead Sponsor Sudhir Srivastava Innovations Pvt. Ltd.
Collaborators: Clicebo Solutions Private Limited
Conditions Soft Tissue Surgeries
Enrollment 365 participants
Start Date 2025-05
Primary Completion 2025-08 (estimated)
Study Completion 2025-11 (estimated)
Updated on ClinicalTrials.gov 2025-05-16